Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206349 · ClinicalTrials.gov registry record
Ability to Cope With Type 1 Diabetes
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 220
- Enrollment target
NCT00206349: Completed study, sponsored by Baylor College of Medicine.
NCT00206349 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00206349 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the relationship that exists between coping skills and blood glucose control. In addition to this, we will study the effect of Type 1 diabetes on coping skills in different age groups, genders, ethnicities, socioeconomic groups, and the duration of diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-05 |
What the finished NCT00206349 record still lists
NCT00206349 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00206349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00206349 about?
NCT00206349 is a clinical study titled "Ability to Cope With Type 1 Diabetes". The purpose of this study is to learn about the relationship that exists between coping skills and blood glucose control. In addition to this, we will study the effect of Type 1 diabetes on coping skills in different age groups, genders, ethnicities, socioeconomic groups, and the duration of diabete...
What is the current status of trial NCT00206349?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2004-06. Estimated completion is 2005-05.
Who is sponsoring clinical trial NCT00206349?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia